An Investigator-Initiated Study to Evaluate PSMA Expression in Patients With High-Grade Gliomas or Brain Metastases With 68Ga-PSMA-11 PET
Status: Recruiting
Location: See all (7) locations...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY
The purpose of this study is to find out whether 68Ga-PSMA-11 PET/CT is effective in assessing tumor uptake (tumor activity seen in cancerous tissue) in participants with high-grade glioma/HGG or brain metastases.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Ability to understand and the willingness to sign (or their legally acceptable representative (LAR) must sign) a written informed consent document
• Adults ≥ 18 years old
• Suspicion for or histologically or cytologically confirmed and previously treated HGG or brain metastases from a primary extracranial malignancy
• Lesion size ≥ 1 cm (for the lesion to be biopsied)
• ECOG performance status ≤ 2 (Karnofsky ≥ 60%)
• Planned to undergo biopsy/resection of brain lesion
Locations
United States
New Jersey
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
RECRUITING
Basking Ridge
Memorial Sloan Kettering Monmouth (All Protocol Activities)
RECRUITING
Middletown
Memorial Sloan Kettering Bergen (All Protocol Activities)
RECRUITING
Montvale
New York
Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities)
RECRUITING
Commack
Memorial Sloan Kettering Westchester (All Protocol Activities)
RECRUITING
Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
RECRUITING
New York
Memorial Sloan Kettering Nassau (All Protocol Activities)
RECRUITING
Uniondale
Contact Information
Primary
Anton Nosov, MD
nosova@mskcc.org
212-639-8575
Backup
Elizabeth Coffee, MD
CoffeeE@mskcc.org
212-639-8011
Time Frame
Start Date: 2024-01-05
Estimated Completion Date: 2027-01-05
Participants
Target number of participants: 30
Treatments
Experimental: Participants with high-grade glioma
Participants with newly diagnosed or recurrent high-grade glioma/HGG or brain metastases
Related Therapeutic Areas
Sponsors
Leads: Memorial Sloan Kettering Cancer Center